NCT07186920

Brief Summary

Brief summary The goal of this clinical trial is to compare two different types of perioperative mechanical ventilation (MV), specifically Protective Mechanical Ventilation (PMV) and MV with the lowest possible Driving Pressure (ΔP), in relation to the appearance of postoperative lung closing, eg atelectasis, in adult patients who are operated. Atelectasis will be evaluated via lung ultrasound. The main questions it aims to answer are:

  • Is MV with lower ΔP better than conventional PMV in keeping lungs more open perioperatively and immediately postoperatively?
  • Does MV with lower ΔP decrease hospital stay, Intensive Care Unit (ICU) need and mortality? Researchers will use lung ultrasound to compare MV with the lowest possible Driving Pressure (ΔP) to Protective Mechanical Ventilation (PMV) to see if any of this is more protective than the other concerning lung atelectasis. All participants will receive perioperative MV. Half of them will receive conventional Protective Mechanical Ventilation (PMV). This will include well known generally protective settings for mechanical ventilation of patients, concerning volumes, pressures, respiratory rate, inspiratory gases and ventilation maneuvers. The rest of participants will be ventilated with the lowest possible Driving Pressure (ΔP). This will be similar to PMV in the chosen volumes, respiratory rate, inspiratory gases and ventilation maneuvers. However, the pressure inside lung at the end of expiration, eg Positive End Expiratory Pressure (PEEP), will be not be preset for every patient. Initially, we will perform a maneuver that will quantify each individual's lung characteristics and mechanics. According to this, we will find the exact PEEP that seems to suit each patients lungs most, and use this perioperatively, trying to provide lungs the best conditions every time. After the completion of the operation, all the patients will be screened for atelectasis, via lung ultrasound, using a well established protocol for the quantification of atelectasis. The results will be statistically analyzed trying to find if any of the forementioned strategies of mechanical ventilation surpasses the other concerning atelectasis appearance. Furthermore efficiency of lung oxygen absorption, hospital stay, ICU need and mortality will be noted.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 20, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 22, 2025

Completed
14 days until next milestone

Study Start

First participant enrolled

October 6, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2026

Completed
Last Updated

February 11, 2026

Status Verified

February 1, 2026

Enrollment Period

3 months

First QC Date

August 20, 2025

Last Update Submit

February 8, 2026

Conditions

Keywords

Postoperative AtelectasisPostoperative Pulmonary AtelectasisPostoperative pulmonary complications (PPCs)Lung ultrasonography scoreLung ultrasoundAtelectasisPulmonary atelectasis

Outcome Measures

Primary Outcomes (1)

  • Lung Ultrasound Score (LUS)

    12 Position Lung Ultrasound will be performed in Post Anesthesia Care Unit (PACU) within 20 minutes postoperatively. In each position the potential scores will be 0,1,2 and 3. 0 --\> 0-2 B-lines 1. --\> \>2 B-lines or presence of small sublpleural consolidations with normal pleural line. 2. --\> Multiple coalescent B-lines or multiple small sublpleural consolidations with thickened or irregular pleural line. 3. --\> Total air loss or subpleural consolidation with diameter bigger than 1x2cm. The total sum of ultrasound scores of each position is marked as LUS.

    Within 20 minutes in PACU.

Secondary Outcomes (10)

  • Rate of Postoperative Respiratory Failure

    Within 30 minutes in PACU

  • Rate of NIMV need

    Period of stay in Post Anesthesia Care Unit (PACU). From time of postoperative transfer to PACU until time of discharge from PACU and return to general clinic, an average of 1 hour.

  • Hospital Stay

    From day of operation until the end of patient stay inside hospital, because of return to home or due to death.

  • ICU need.

    From day of operation until the end of patient stay inside hospital, because of return to home or due to death.

  • ICU stay

    From day of operation until the end of patient stay inside hospital, because of return to home or due to death.

  • +5 more secondary outcomes

Study Arms (2)

Lung Protective Ventilation

OTHER

CONVENTIONAL LUNG PROTECTIVE VENTILATION This group is mechanically ventilated with Invasive Mechanical Ventilation with PEEP 8 cm H20 Tidal Volume (VT) 8 ml/kg Ideal Body Weight (IBW) Respiratory Rate (RR) --\> PaCO2 = 35-45 mmHg Inspired Oxygen Fraction (FiO2) 0.4 - 0.5 --\> Pulse Saturation Oxygen (SpO2) \> 93% Recruitment Maneuver (as described) every hour

Procedure: Lung Protective Ventilation

Minimum Driving Pressure

ACTIVE COMPARATOR

This group is mechanically ventilated with Invasive Mechanical Ventilation with PEEP; Initially 8 cm H20, titrated at level with Minimum Driving Pressure after first recruitment - titration maneuver followed by new recruitment maneuver VT 8 ml/kg IBW RR --\> PaCO2 = 35-45 mmHg FiO2 0.4 - 0.5 --\> SpO2 \> 93% Recruitment Maneuver (as described) every hour

Procedure: PEEP titration for Minimum Driving Pressure

Interventions

This group is mechanically ventilated with Invasive Mechanical Ventilation with Volume Control Ventilation mode with PEEP Initially 8 cm H2O. Afterwards, the lungs are recruited with the aforementioned maneuver. During subsequent derecruitment, PEEP is decreased by 2 cm H20 and compliance is noted in each stage. The goal is to find PEEP with maximum compliance (Cmax). A new recruitment maneuver follows and during derecruitment PEEP is set at the optimum value that was previously defined. VT 8 ml/kg IBW RR --\> PaCO2 = 35-45 mmHg FiO2 0.4 - 0.5 --\> SpO2 \> 93% Recruitment Maneuver (as described) every hour

Also known as: Maximum compliance mechanical ventilation, Cmax Mechanical Ventilation
Minimum Driving Pressure

This group is mechanically ventilated with Invasive Mechanical Ventilation with Volume Control Ventilation mode with PEEP 8 cm H2O. VT 8 ml/kg IBW RR --\> PaCO2 = 35-45 mmHg FiO2 0.4 - 0.5 --\> SpO2 \> 93% Recruitment Maneuvers (as described) every hour

Lung Protective Ventilation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \>17 years old
  • Surgery with general anesthesia \& invasive mechanical ventilation
  • ASA score I-III

You may not qualify if:

  • \<18 years old
  • Preoperative ARISCAT score estimation \<26
  • Women during pregnancy or just given birth
  • Other type of anesthesia (Not general)
  • Contraindication of administration of neuromuscular blockade agents.
  • Contraindication of cease of spontaneous ventilation.
  • Mechanical ventilation without endotracheal intubation.
  • Severe heart failure / History of ischemic heart disease.
  • Moderate or severe chronic obstructive lung disease or interstitial lung disease.
  • History of operation in heart, lung or diaphragm.
  • Presence of new active pathology in respiratory system at the beginning of surgery (infection / trauma / anatomic disorder).
  • Severe intraoperative respiratory complication (laryngospasm / bronchospasm / anaphylaxis).
  • Immediate postoperative need for continuation of IMV.
  • Patient denial of participation in the trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Patras

Pátrai, 26504, Greece

Location

MeSH Terms

Conditions

Pulmonary Atelectasis

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract Diseases

Study Officials

  • Diamanto Aretha, A. Professor

    University of Patras

    STUDY CHAIR
  • Nektaria Xirouchaki, Consultant

    University of Crete

    STUDY DIRECTOR
  • Eumorfia Kondili, Professor

    University of Crete

    STUDY DIRECTOR
  • Antonios Kostouros, Resident

    University of Patras

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anesthesiology Resident, Antonios Kostouros

Study Record Dates

First Submitted

August 20, 2025

First Posted

September 22, 2025

Study Start

October 6, 2025

Primary Completion

December 31, 2025

Study Completion

January 15, 2026

Last Updated

February 11, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

Locations